Skip to Content

Bloomios Inc BLMS

Morningstar Rating
$0.00 0.00 (177.78%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BLMS is trading within a range we consider fairly valued.
Price
$0.00
Fair Value
$9.67
Uncertainty
Extreme
1-Star Price
$1.66
5-Star Price
$2.58
Economic Moat
Mllrv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BLMS is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.85
Bid/Ask
$0.00 / $0.00
Market Cap
$96,709.87
Volume/Avg
10.7 Mil / 675,746

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.00
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Bloomios Inc manufactures, markets, and distributes U.S. hemp-derived supplements and cosmetic products through wholesale distribution channels in the United States of America. It offers its private-label and white-label customers large collections of customizable hemp products that include over 80 products across 7 categories in addition to custom formulation and manufacturing services. Its product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
3

Valuation

Metric
BLMS
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
0.00
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
BLMS
Quick Ratio
0.01
Current Ratio
0.01
Interest Coverage
−13.15
Quick Ratio
BLMS

Profitability

Metric
BLMS
Return on Assets (Normalized)
−82.86%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−104.90%
Return on Assets
BLMS
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ALqcjkhsgrHckm$74.6 Bil
MKKGY
Merck KGaA ADRVjmgyptvbtNjkvkb$70.9 Bil
HLN
Haleon PLC ADRWrtztbbckMvq$37.0 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRTqvfqphbZwx$14.9 Bil
VTRS
Viatris IncPgbpdbkbXyp$13.9 Bil
RDY
Dr Reddy's Laboratories Ltd ADRHgcyyqbxkZnzd$12.2 Bil
CTLT
Catalent IncKtnczlbsQypkcmp$10.3 Bil
PRGO
Perrigo Co PLCBcksngxxYfvm$4.3 Bil
CURLF
Curaleaf Holdings IncPrrpvfkyKfbhf$3.9 Bil
PBH
Prestige Consumer Healthcare IncLfzvfrttCxnrgm$3.4 Bil

Sponsor Center